ICD-10 Code B43.9 | Chromomycosis, unspecified Symptoms, Diagnosis, Billing

Chromomycosis, unspecified is a chronic fungal infection caused by various species of fungi, primarily affecting the skin and subcutaneous tissues. It is clinically significant due to its potential to cause disfigurement and secondary infections. Accurate coding with ICD-10 Code B43.9 facilitates proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this condition.

What is ICD-10 Code B43.9 for Chromomycosis, unspecified?

ICD-10 Code B43.9 represents Chromomycosis, unspecified, a fungal infection characterized by the presence of chromoblasts in the skin. This code is used when the specific type of chromomycosis is not identified. It is essential for clinical documentation and billing when a patient presents with symptoms of a fungal infection without a specified etiology.

ICD-10 Code B43.9 – Clinical Definition and Explanation of Chromomycosis, unspecified

Chromomycosis, unspecified is caused by dematiaceous fungi, which can lead to chronic skin lesions and systemic complications if untreated. The condition requires medical attention to prevent progression and associated morbidity.

Key Clinical Features:

• Chronic skin lesions that may be raised or ulcerated
• Possible systemic involvement in immunocompromised patients
• Commonly presents in tropical and subtropical regions
• May cause significant morbidity if left untreated

ICD-10 Code B43.9 for Chromomycosis, unspecified – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B43.9 is utilized to document the patient's symptoms, assessment findings, and treatment plans related to chromomycosis. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B43.9 for Chromomycosis, unspecified Mean in SOAP Notes?

ICD-10 Code B43.9 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of chromomycosis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B43.9 – Chromomycosis, unspecified

Prompt treatment of chromomycosis is essential to prevent complications and improve patient outcomes. Hospitalization may be necessary for severe cases.

Antibiotic Therapy:

• Itraconazole (first-line) for 6-12 months
• Terbinafine (alternative) for 6-12 months
• Fluconazole (alternative) for 6-12 months
• Amphotericin B for severe cases

Supportive Care:

• Wound care and hygiene management
• Pain management as needed
• Monitoring for secondary infections
• Patient education on skin care

Infection Control:

• Implement standard precautions during treatment
• Educate patients on hygiene to prevent spread
• Monitor for outbreaks in endemic areas

How to Document Symptoms of Chromomycosis, unspecified (ICD-10 B43.9) in SOAP Notes

Subjective:

• Patient reports chronic skin lesions with itching
• History of exposure to contaminated soil or vegetation
• No known allergies or previous fungal infections
• Symptoms have persisted for several months

Objective:

• Skin examination reveals raised, ulcerated lesions
• No fever or systemic signs of infection
• Laboratory tests show presence of fungal elements
• Vital signs within normal limits

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Chromomycosis, unspecified (ICD-10 Code B43.9)

Assessment:

• Diagnosis: Chromomycosis, unspecified, moderate severity
• ICD-10 Code: B43.9
• Contributing factors: History of exposure to contaminated environments
• No known immunocompromised status noted

Plan:

• Initiate treatment with itraconazole for 6 months
• Educate patient on skin care and hygiene practices
• Schedule follow-up in 4 weeks to assess treatment response
• Monitor for any signs of systemic involvement

Treatment & Plan Section for ICD-10 Code B43.9 – Chromomycosis, unspecified

• First-line treatment with itraconazole or terbinafine
• Patient education on hygiene and skin care
• Regular follow-up appointments to monitor treatment efficacy
• Consider referral to a dermatologist for complex cases

Using ICD-10 Code B43.9 for Chromomycosis, unspecified in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings
• Use B43.9 in conjunction with appropriate CPT codes for billing
• Maintain compliance with coding guidelines to support claims
• Document treatment plans that align with clinical guidelines

Related ICD-10 Codes Often Used with Chromomycosis, unspecified

• B43.0 – Chromomycosis due to Fonsecaea pedrosoi
• B43.1 – Chromomycosis due to Cladophialophora carrionii
• B43.2 – Chromomycosis due to Phialophora verrucosa
• B43.8 – Other chromomycosis

ICD-10 Code B43.9 in Medical Billing and Insurance for Chromomycosis, unspecified

ICD-10 Code B43.9 is critical in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and symptoms clearly
• Use B43.9 in appropriate clinical settings to support claims
• Ensure all chart elements align with coding requirements
• Maintain accurate records to facilitate reimbursement

Common CPT Pairings: